Legal & General Group
APYX icon

Legal & General Group’s Apyx Medical APYX Stock Holding History

Legal & General Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,391
Closed -$22K – 3527
2022
Q1 		$22K Hold
3,391
– – ﹤0.01% 3208
2021
Q4 		$43K Buy
3,391
+31
+0.9% +$434 ﹤0.01% 3066
2021
Q3 		$47K Hold
3,360
– – ﹤0.01% 2990
2021
Q2 		$35K Buy
3,360
+782
+30% +$7.75K ﹤0.01% 3072
2021
Q1 		$25K Sell
2,578
-552
-18% -$5.52K ﹤0.01% 3035
2020
Q4 		$23K Hold
3,130
– – ﹤0.01% 3030
2020
Q3 		$15K Sell
3,130
-1,434
-31% -$7.1K ﹤0.01% 3068
2020
Q2 		$25K Hold
4,564
– – ﹤0.01% 2963
2020
Q1 		$16K Sell
4,564
-1,165
-20% -$7.82K ﹤0.01% 2983
2019
Q4 		$48K Buy
5,729
+178
+3% +$1.29K ﹤0.01% 2823
2019
Q3 		$38K Hold
5,551
– – ﹤0.01% 2849
2019
Q2 		$33K Buy
+5,551
New +$30.2K ﹤0.01% 2959

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.25% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Legal & General Group's APYX Position: Q2 2022 in Review

Legal & General Group sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 3,391 shares — an estimated $22K sold.

Legal & General Group first reported a position in APYX in Q2 2019 and held it in 12 quarters. The position peaked at $48K in Q4 2019. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

  • Legal & General Group reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
  • Legal & General Group sold 3,391 Apyx Medical shares in Q2 2022, an estimated $22K.
  • Legal & General Group first reported a position in Apyx Medical in Q2 2019 and held it in 12 quarters.
  • Legal & General Group's Apyx Medical position peaked at $48K in Q4 2019.
  • 63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Legal & General Group's 13F filing for Q2 2022, filed 22 Aug 2022.